2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid ‐Induced Osteoporosis
This article is protected by copyright. All rights reserved. (Source: Arthritis Care and Research)
Source: Arthritis Care and Research - September 21, 2017 Category: Rheumatology Authors: Lenore Buckley, Gordon Guyatt, Howard Fink, Timothy McAlindon Tags: Reply to Letter to the editor Source Type: research
Trajectories of fear ‐avoidance beliefs on physcial activity over two years in people with rheumatoid arthritis
ConclusionsStable trajectories of fear‐avoidance beliefs on physical activity exist among people with RA. Fear‐avoidance may be targeted more effectively by tailoring physical activity promotion to vulnerable socioeconomic groups, men and those with high activity limitation and anxiety/depression.This article is protected by copyright. All rights reserved. (Source: Arthritis Care and Research)
Source: Arthritis Care and Research - September 21, 2017 Category: Rheumatology Authors: Ingrid Demmelmaier, Annika Bj örk, Alyssa B. Dufour, Birgitta Nordgren, Christina H. Opava Tags: Original Article Source Type: research
Timing and impact of decisions to adjust disease ‐modifying antirheumatic drug therapy for rheumatoid arthritis patients with active disease
ConclusionAdjusting DMARDs within 90 days was associated with shorter times to LDAS, but many patients with persistent MHDAS waited more than 90 days to adjust DMARDs. Interventions are needed to address the timeliness of DMARD adjustments for RA patients with MHDAS.This article is protected by copyright. All rights reserved. (Source: Arthritis Care and Research)
Source: Arthritis Care and Research - September 21, 2017 Category: Rheumatology Authors: Yomei Shaw, Chung ‐Chou H. Chang, Marc C. Levesque, Julie M. Donohue, Kaleb Michaud, Mark S. Roberts Tags: Original Article Source Type: research
Comment on 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid ‐Induced Osteoporosis
This article is protected by copyright. All rights reserved. (Source: Arthritis Care and Research)
Source: Arthritis Care and Research - September 21, 2017 Category: Rheumatology Authors: Michael Maricic, Chad Deal, Robin Dore, Andrew Laster Tags: Letter to the editor Source Type: research
Efficacy of a Work Disability Prevention Program for People with Rheumatic and Musculoskeletal Conditions: The Work It Study Trial
ConclusionThe intervention did not have an effect on work limitations but reduced work loss. The intervention can be delivered by trained rehabilitation therapists.This article is protected by copyright. All rights reserved. (Source: Arthritis Care and Research)
Source: Arthritis Care and Research - September 21, 2017 Category: Rheumatology Authors: Julie J. Keysor, Michael P. LaValley, Carrie Brown, David T. Felson, Rawan A. AlHeresh, Molly W. Vaughan, Robert Yood, John I. Reed, Saralynn J. Allaire Tags: Original Article Source Type: research
Coping strategies, psychological impact and support preferences of men with rheumatoid arthritis: a multicentre survey
ConclusionsSome men accept and adapt to their RA, but others (43%) report severe disease, less effective coping and poor psychological status. Men's preferences for support take the practical form, with a focus on expanding their knowledge.This article is protected by copyright. All rights reserved. (Source: Arthritis Care and Research)
Source: Arthritis Care and Research - September 21, 2017 Category: Rheumatology Authors: Caroline A Flurey, Sarah Hewlett, Karen Rodham, Alan White, Robert Noddings, John R Kirwan Tags: Original Article Source Type: research
Lymphoma in the Tofacitinib Rheumatoid Arthritis Clinical Development Program
ConclusionsIn the tofacitinib RA clinical development program, lymphoma rates were stable over time and there were minimal differences in baseline characteristics of patients with and without lymphoma.This article is protected by copyright. All rights reserved. (Source: Arthritis Care and Research)
Source: Arthritis Care and Research - September 21, 2017 Category: Rheumatology Authors: Xavier Mariette, Connie Chen, Pinaki Biswas, Kenneth Kwok, Mary G. Boy Tags: Original Article Source Type: research
Combination of capillaroscopic and ultrasonographic evaluations in systemic sclerosis: Results of a cross ‐sectional study
ConclusionsMicrovascular damages evaluated by NC and macrovascular features like UAO assessed by PDUS show concordant associations with the main digital manifestations of the disease.This article is protected by copyright. All rights reserved. (Source: Arthritis Care and Research)
Source: Arthritis Care and Research - September 12, 2017 Category: Rheumatology Authors: Alain Lescoat, Guillaume Coiffier, Marine de Carlan, Catherine Droitcourt, Alice Ballerie, Cazalets Claire, Aleth Perdriger, J égo Patrick Tags: Brief Report Source Type: research
The projected burden of osteoarthritis and rheumatoid arthritis in Australia: A population ‐level analysis
ConclusionsOA and RA are costly conditions that will impose an increasing healthcare burden at the population level. These projections provide tangible data that can be utilised to map future health service provision to expected need.This article is protected by copyright. All rights reserved. (Source: Arthritis Care and Research)
Source: Arthritis Care and Research - September 12, 2017 Category: Rheumatology Authors: Ilana N Ackerman, Clare Pratt, Alexandra Gorelik, Danny Liew Tags: Original Article Source Type: research
Current Physical Activity Monitors in Hip and Knee Osteoarthritis: A Review
(Source: Arthritis Care and Research)
Source: Arthritis Care and Research - September 6, 2017 Category: Rheumatology Authors: Maik Sliepen, Mirko Brandes, Dieter Rosenbaum Tags: Review Article Source Type: research
Rheumatoid Arthritis Treatment After Methotrexate: The Durability of Triple Therapy Versus Etanercept
ConclusionIn RA patients with suboptimal methotrexate response randomized to receive triple therapy or methotrexate‐etanercept, the former was found to be significantly more durable. Given cost differences and similar outcomes, the variable durability demonstrated provides additional evidence supporting conventional combinations over biologic agent combinations as the first choice after methotrexate inadequate response. (Source: Arthritis Care and Research)
Source: Arthritis Care and Research - September 6, 2017 Category: Rheumatology Authors: Shana M. Peper, Robert Lew, Ted Mikuls, Mary Brophy, Denis Rybin, Hongseng Wu, James O'dell Tags: Original Article Source Type: research
Unexpected Cause of Rhabdomyolysis and Proximal Muscle Weakness
(Source: Arthritis Care and Research)
Source: Arthritis Care and Research - September 6, 2017 Category: Rheumatology Authors: Samuel H. Poon, Lanu Stoddart Tags: Clinicopathologic Conference Source Type: research
Treatment of Rheumatoid Arthritis With Anti –Tumor Necrosis Factor or Tocilizumab Therapy as First Biologic Agent in a Global Comparative Observational Study
ConclusionPatients initiating tocilizumab experienced greater effectiveness and drug survival than those initiating TNFi in an observational setting. (Source: Arthritis Care and Research)
Source: Arthritis Care and Research - September 6, 2017 Category: Rheumatology Authors: Ernest H. Choy, Corrado Bernasconi, Maher Aassi, Jose Fernando Molina, Oscar Massimiliano Epis Tags: Original Article Source Type: research
Medical expenditures and earnings losses among US adults with arthritis in 2013
ConclusionTotal national arthritis‐attributable medical care expenditures and earnings losses among adults with arthritis were $303.5 billion in 2013. High arthritis‐attributable medical expenditures might be reduced by greater efforts to reduce pain and improve function. The high earnings losses were largely attributable to the substantially lower prevalence of working among those with arthritis compared with those without, signaling the need for interventions that keep people with arthritis in the work force.This article is protected by copyright. All rights reserved. (Source: Arthritis Care and Research)
Source: Arthritis Care and Research - September 1, 2017 Category: Rheumatology Authors: Louise B Murphy, Miriam G Cisternas, David J Pasta, Charles G Helmick, Edward H Yelin Tags: Original Article Source Type: research
Serum levels of HMGB1 and sRAGE are associated to extraglandular involvement and disease activity as defined by ESSDAI in Sj ögren's syndrome
ConclusionsSerum levels of total HMGB1 and sRAGE were elevated in patients with SS compared to HC and correlated with disease activity as measured by the ESSDAI. Patients with extraglandular involvement revealed high HMGB1 serum levels.This article is protected by copyright. All rights reserved. (Source: Arthritis Care and Research)
Source: Arthritis Care and Research - September 1, 2017 Category: Rheumatology Authors: Anna ‐Maria Kanne, Maike Jülich, Amira Mahmutovic, Isabella Tröster, Bettina Sehnert, Vilma Urbonaviciute, Reinhard E. Voll, Florian Kollert Tags: Brief Report Source Type: research
